Bayer reported €5.68B in Cost of Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Akzo Nobel AKZA:NA 1.82B 276M
Alcon AG ALC:SW 922.43M 49.57M
Amarin AMRN:US $ 35.81M 13.57M
Arkema AKE:FP € 2350M 215M
Artemis Alpha ATS:LN 50.7M 12.5M
AstraZeneca AZN:LN 156386.94M 17145.23M
BASF BAS:GR € 17135M 54M
Bayer BAYN:GR € 5680M 504M
Corteva Inc CTVA:US $ 3.32B 599M
Covestro 1COV:GR 3.78B 286M
Essilor EI:FP 4.39B 134M
Fresenius FRE:GR € 7340M 178M
Fresenius Medical Care FME:GR € 3411M 120.73M
Givaudan GIVN:VX 2.19B 257M
GlaxoSmithKline GSK:LN 213600M 55400M
Hikma Pharmaceutical HIK:LN 48.46B 267.66M
Johnson Matthey JMAT:LN 693.3B 110.5B
Linde LIN:GR 4.94B 142M
Lonza Group LONN:SW 1.79B 14M
Merck MRK:GR € 2109M 122M
Novartis NOVN:VX SF 3749M 6M
Nutrien Ltd NTR:CN C$ 8.51B 4.11B
Philips PHIA:NA € 2445M 38M
Ppg Industries PPG:US $ 2954M 256M
SAP SAP:GR € 2143M 99M
Solvay SOLB:BB € 2993M 189M
Umicore UMI:BB 13B 2.27B